Bringing handheld echOpen ultrasound to link neighborhood clinics with Jean Verdier Hospital

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The intervention introduces the echOpen handheld ultrasound probe in a three-phase rollout across the Jean Verdier Rapid Diagnostic Unit (UDR), referring outpatient clinics, and a mobile Health Bus. Each phase begins with clinician training followed by prospective use of the probe during patient evaluations, with data collected on time to diagnosis, diagnostic accuracy, and use of additional tests. The protocol enrolls consenting adults referred to participating sites and excludes those on the UDR iron-deficiency anemia pathway, patients with BMI >34.9 kg/m2, life‑threatening emergencies, or those unable to communicate in French without a translator. Primary process outcomes include diagnostic timing and downstream changes such as direct access to biopsy and reduced complementary examinations.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Adult patient over 18 years of age
2. Patient with signed informed consent
3. Patient managed by:

   * one of the structures involved (UDR/ SAU Jean Verdier, MSP Pantin, Cabinet Médical du Dr TAYBALY à Aulnay-sous-Bois) for referral to the UDR for rapid diagnosis (phases 1 and 2)
   * the Health Bus (phase 3)

Exclusion Criteria:

1. Patient on the UDR iron-deficiency anemia clinical pathway
2. Patient deprived of liberty by judicial or administrative decision
3. Patient who does not speak French and cannot benefit from the presence of a relative or translator (physical or online)
4. Patient with a contraindication to the use of EchOPen:

   * patients with a body mass index greater than 34.9 kg/m2
   * life-threatening patients requiring emergency medical care.

Where it's running

• Unite de Diagnostic Rapide - Medecine Interne Hopital Jean Verdier
  Bondy, France Recruiting

Study contacts

• Study coordinator: Anne BOURGARIT, PUPH
• Email: anne.bourgarit@aphp.fr
• Phone: 00331 48 02 61 59

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• AI analysis of ECGs to detect structural heart disease

  This project will test whether AI can read traditional and wearable ECGs to find undiagnosed valve disease, pulmonary hypertension, and heart failure in adults.

  Recruiting at 6 sites Imperial College London · Bristol and 5 other locations · NCT07057466

• Heart failure with preserved ejection fraction in people with COPD: clinical course and prognosis

  This project will see how often HFpEF appears in people aged 50–70 hospitalized with COPD and whether having HFpEF changes their symptoms, exercise capacity, and prognosis.

  Recruiting at 2 sites National Medical Research Center for Therapy and Preventive Medicine · Kazan' and 1 other locations · NCT07375433

• Risk-based lung cancer screening in COPD patients using ML and clinical models

  This study tests whether a PLCOm2012 risk model plus a machine learning model can spot COPD patients at high risk for lung cancer to see if they benefit from low-dose CT screening.

  Recruiting Vejle Hospital · Vejle, Region Syddanmark · NCT07848815

• AI-Personalized Discharge Education After Lung Cancer Surgery

  This study tests whether an AI-generated, personalized discharge guide helps patients recover better after lung cancer surgery compared with standard discharge education.

  Recruiting Xiamen University · Siping, Jilin · NCT07827183

• Next Generation Delivery System (NGDS) for SBRT in thorax and upper abdomen

  A study tests a new machine to deliver SBRT more quickly and comfortably for adults with thoracic or upper abdominal cancers.

  Recruiting at 2 sites Varian, a Siemens Healthineers Company · St Louis, Missouri and 1 other locations · NCT07824583

• Low-Intensity Endurance Exercise to Help Lung Cancer-Related Fatigue

  This trial tests whether light, regular endurance exercise can help reduce fatigue and improve quality of life for people with lung cancer in addition to their usual care.

  Recruiting Taipei Medical University · Taipei · NCT07806682

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.